Awareness of the Causes Leading to Surgical Ablation of Ovarian Function in Premenopausal Breast Cancer—A Single-Center Analysis

<i>Background and Objectives</i>: Ovarian surgical ablation (OSA) in estrogen receptor-positive (ER+) breast cancer is usually performed to halt ovarian function in premenopausal patients. Since alternative pharmacological therapy exists and few studies have investigated why surgery is s...

Full description

Bibliographic Details
Main Authors: Joana Correia Oliveira, Filipa Costa Sousa, Inês Gante, Margarida Figueiredo Dias
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/57/4/385
_version_ 1827695031284137984
author Joana Correia Oliveira
Filipa Costa Sousa
Inês Gante
Margarida Figueiredo Dias
author_facet Joana Correia Oliveira
Filipa Costa Sousa
Inês Gante
Margarida Figueiredo Dias
author_sort Joana Correia Oliveira
collection DOAJ
description <i>Background and Objectives</i>: Ovarian surgical ablation (OSA) in estrogen receptor-positive (ER+) breast cancer is usually performed to halt ovarian function in premenopausal patients. Since alternative pharmacological therapy exists and few studies have investigated why surgery is still performed, we aimed to analyze the reasons for the use of OSA despite the remaining controversy. <i>Materials and Methods</i>: Premenopausal ER+ breast cancer patients treated at a tertiary center (2005–2011) were selected, and patients with germline mutations were excluded. <i>Results</i>: Seventy-nine patients met the inclusion criteria. Globally, the main reasons for OSA included: continued menstruation despite hormone therapy with or without ovarian medical ablation (OMA) (34.2%), patient informed choice (31.6%), disease progression (16.5%), gynecological disease requiring surgery (13.9%), and tamoxifen intolerance/contraindication (3.8%). In women aged ≥45 years, patient choice was significantly more frequently the reason for OSA (47.4% versus 17.1% (<i>p</i> = 0.004)). For those aged <45 years, salvation attempts were significantly more frequent as compared to older women (26.8% versus 5.3% (<i>p</i> = 0.01)). In 77.8% of women undergoing OSA with menstrual cycle maintenance, surgery was performed 1–5 years after diagnosis, while surgery was performed earlier (0–3 months after diagnosis) in patients undergoing OSA as an informed choice (56.0%), as a salvation attempt (53.8%), or due to gynecological disease (63.6%). The leading reason for OSA in women previously undergoing OMA was continued menstruation (60.0%). <i>Conclusions</i>: This study suggests a possible failure of pharmacological ovarian suppression and reinforces the need for shared decision-making with patients when discussing treatment strategies, although validation by further studies is warranted due to our limited sample size.
first_indexed 2024-03-10T12:16:57Z
format Article
id doaj.art-fd073404c7234c909b17836eabd75df2
institution Directory Open Access Journal
issn 1010-660X
1648-9144
language English
last_indexed 2024-03-10T12:16:57Z
publishDate 2021-04-01
publisher MDPI AG
record_format Article
series Medicina
spelling doaj.art-fd073404c7234c909b17836eabd75df22023-11-21T15:49:30ZengMDPI AGMedicina1010-660X1648-91442021-04-0157438510.3390/medicina57040385Awareness of the Causes Leading to Surgical Ablation of Ovarian Function in Premenopausal Breast Cancer—A Single-Center AnalysisJoana Correia Oliveira0Filipa Costa Sousa1Inês Gante2Margarida Figueiredo Dias3Gynecology Department, Centro Hospitalar e Universitário de Coimbra, Praceta Prof. Mota Pinto, 3004-561 Coimbra, PortugalGynecology Department, Centro Hospitalar e Universitário de Coimbra, Praceta Prof. Mota Pinto, 3004-561 Coimbra, PortugalGynecology Department, Centro Hospitalar e Universitário de Coimbra, Praceta Prof. Mota Pinto, 3004-561 Coimbra, PortugalGynecology Department, Centro Hospitalar e Universitário de Coimbra, Praceta Prof. Mota Pinto, 3004-561 Coimbra, Portugal<i>Background and Objectives</i>: Ovarian surgical ablation (OSA) in estrogen receptor-positive (ER+) breast cancer is usually performed to halt ovarian function in premenopausal patients. Since alternative pharmacological therapy exists and few studies have investigated why surgery is still performed, we aimed to analyze the reasons for the use of OSA despite the remaining controversy. <i>Materials and Methods</i>: Premenopausal ER+ breast cancer patients treated at a tertiary center (2005–2011) were selected, and patients with germline mutations were excluded. <i>Results</i>: Seventy-nine patients met the inclusion criteria. Globally, the main reasons for OSA included: continued menstruation despite hormone therapy with or without ovarian medical ablation (OMA) (34.2%), patient informed choice (31.6%), disease progression (16.5%), gynecological disease requiring surgery (13.9%), and tamoxifen intolerance/contraindication (3.8%). In women aged ≥45 years, patient choice was significantly more frequently the reason for OSA (47.4% versus 17.1% (<i>p</i> = 0.004)). For those aged <45 years, salvation attempts were significantly more frequent as compared to older women (26.8% versus 5.3% (<i>p</i> = 0.01)). In 77.8% of women undergoing OSA with menstrual cycle maintenance, surgery was performed 1–5 years after diagnosis, while surgery was performed earlier (0–3 months after diagnosis) in patients undergoing OSA as an informed choice (56.0%), as a salvation attempt (53.8%), or due to gynecological disease (63.6%). The leading reason for OSA in women previously undergoing OMA was continued menstruation (60.0%). <i>Conclusions</i>: This study suggests a possible failure of pharmacological ovarian suppression and reinforces the need for shared decision-making with patients when discussing treatment strategies, although validation by further studies is warranted due to our limited sample size.https://www.mdpi.com/1648-9144/57/4/385breast cancerreceptorestrogensalpingo-oophorectomyantineoplastic agentshormonal
spellingShingle Joana Correia Oliveira
Filipa Costa Sousa
Inês Gante
Margarida Figueiredo Dias
Awareness of the Causes Leading to Surgical Ablation of Ovarian Function in Premenopausal Breast Cancer—A Single-Center Analysis
Medicina
breast cancer
receptor
estrogen
salpingo-oophorectomy
antineoplastic agents
hormonal
title Awareness of the Causes Leading to Surgical Ablation of Ovarian Function in Premenopausal Breast Cancer—A Single-Center Analysis
title_full Awareness of the Causes Leading to Surgical Ablation of Ovarian Function in Premenopausal Breast Cancer—A Single-Center Analysis
title_fullStr Awareness of the Causes Leading to Surgical Ablation of Ovarian Function in Premenopausal Breast Cancer—A Single-Center Analysis
title_full_unstemmed Awareness of the Causes Leading to Surgical Ablation of Ovarian Function in Premenopausal Breast Cancer—A Single-Center Analysis
title_short Awareness of the Causes Leading to Surgical Ablation of Ovarian Function in Premenopausal Breast Cancer—A Single-Center Analysis
title_sort awareness of the causes leading to surgical ablation of ovarian function in premenopausal breast cancer a single center analysis
topic breast cancer
receptor
estrogen
salpingo-oophorectomy
antineoplastic agents
hormonal
url https://www.mdpi.com/1648-9144/57/4/385
work_keys_str_mv AT joanacorreiaoliveira awarenessofthecausesleadingtosurgicalablationofovarianfunctioninpremenopausalbreastcancerasinglecenteranalysis
AT filipacostasousa awarenessofthecausesleadingtosurgicalablationofovarianfunctioninpremenopausalbreastcancerasinglecenteranalysis
AT inesgante awarenessofthecausesleadingtosurgicalablationofovarianfunctioninpremenopausalbreastcancerasinglecenteranalysis
AT margaridafigueiredodias awarenessofthecausesleadingtosurgicalablationofovarianfunctioninpremenopausalbreastcancerasinglecenteranalysis